{"id":"https://openalex.org/W2000579472","doi":"https://doi.org/10.1002/ddr.430070104","title":"The neuropharmacological profile of tefludazine, a potential antipsychotic drug with dopamine and serotonin receptor antagonistic effects","display_name":"The neuropharmacological profile of tefludazine, a potential antipsychotic drug with dopamine and serotonin receptor antagonistic effects","publication_year":1986,"publication_date":"1986-01-01","ids":{"openalex":"https://openalex.org/W2000579472","doi":"https://doi.org/10.1002/ddr.430070104","mag":"2000579472"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.430070104","doi":"https://doi.org/10.1002/ddr.430070104","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430070104","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"O. Svendsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"O. Svendsen","raw_affiliation_strings":["Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark","Research Departments, H. Lundbeck A/S, Ottiliavej 7\u2010\u20109, DK 2500 Copenhagen\u2010Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]},{"raw_affiliation_string":"Research Departments, H. Lundbeck A/S, Ottiliavej 7\u2010\u20109, DK 2500 Copenhagen\u2010Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111781850","display_name":"J\ufffdrn Arnt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"J. Arnt","raw_affiliation_strings":["Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042606326","display_name":"Vita Boeck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"V. Boeck","raw_affiliation_strings":["Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047726476","display_name":"Klaus Peter B\u00f8ges\u00f8","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"K. P. B\u00f8ges\u00f8","raw_affiliation_strings":["Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037459343","display_name":"Anne Vibeke Christensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"A. V. Christensen","raw_affiliation_strings":["Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108475318","display_name":"John Hyttel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"J. Hyttel","raw_affiliation_strings":["Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111809453","display_name":"J.\u2010J. Larsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"J.\u2010J. Larsen","raw_affiliation_strings":["Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, H. Lundbeck A/S, Copenhagen-Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I133593841"],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":2.6444,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.89145031,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"1","first_page":"35","last_page":"47"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8960000276565552,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8960000276565552,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0957999974489212,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8180000185966492},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonism","display_name":"dopamine receptor antagonism","score":0.8539999723434448},{"id":"https://openalex.org/keywords/serotonin-receptor-antagonism","display_name":"serotonin receptor antagonism","score":0.972000002861023},{"id":"https://openalex.org/keywords/catalepsy","display_name":"catalepsy","score":0.9240000247955322},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.8180000185966492},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.7699999809265137},{"id":"https://openalex.org/keywords/alpha-adrenergic-blockade","display_name":"alpha-adrenergic blockade","score":0.6809999942779541},{"id":"https://openalex.org/keywords/methiothepin","display_name":"methiothepin","score":0.8040000200271606},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.8870000243186951},{"id":"https://openalex.org/keywords/fluphenazine","display_name":"fluphenazine","score":0.8550000190734863},{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.8700000047683716},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.871999979019165},{"id":"https://openalex.org/keywords/flupentixol","display_name":"flupentixol","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7385099530220032},{"id":"https://openalex.org/C2776978879","wikidata":"https://www.wikidata.org/wiki/Q58376","display_name":"Fluphenazine","level":4,"score":0.6767582297325134},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.6650735139846802},{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.6538923978805542},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5879971981048584},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.5866384506225586},{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.5862647294998169},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4961787164211273},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4959143102169037},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.4737354516983032},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.428851842880249},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4149044156074524},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3432196378707886},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3362342119216919},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.23208099603652954},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19788184762001038},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06310740113258362},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ddr.430070104","doi":"https://doi.org/10.1002/ddr.430070104","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430070104","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W46061604","https://openalex.org/W146815150","https://openalex.org/W1977134332","https://openalex.org/W1989199700","https://openalex.org/W1989318971","https://openalex.org/W1989639115","https://openalex.org/W1999898236","https://openalex.org/W2000317490","https://openalex.org/W2002464785","https://openalex.org/W2005169355","https://openalex.org/W2008405016","https://openalex.org/W2012301147","https://openalex.org/W2015547448","https://openalex.org/W2023633570","https://openalex.org/W2026473192","https://openalex.org/W2026485584","https://openalex.org/W2038341589","https://openalex.org/W2053813137","https://openalex.org/W2056070025","https://openalex.org/W2058254836","https://openalex.org/W2059317623","https://openalex.org/W2060172635","https://openalex.org/W2066787189","https://openalex.org/W2088445837","https://openalex.org/W2094839156","https://openalex.org/W2126979333","https://openalex.org/W2341140535","https://openalex.org/W2422726853","https://openalex.org/W4298998623"],"related_works":["https://openalex.org/W1978255865","https://openalex.org/W2070220778","https://openalex.org/W2414603740","https://openalex.org/W2033976370","https://openalex.org/W4237887446","https://openalex.org/W1997615112","https://openalex.org/W2125815853","https://openalex.org/W2033274638","https://openalex.org/W2430155187","https://openalex.org/W2056605202"],"abstract_inverted_index":{"Abstract":[0],"The":[1,148],"neuropharmacology":[2],"of":[3,35,51,56,67,78,124,152,156,182],"tefludazine,":[4],"a":[5,32,171],"new":[6],"neuroleptic":[7],"with":[8,16,91,94,179],"phenylindan":[9],"structure,":[10],"has":[11,170],"been":[12],"investigated":[13],"in":[14,31,38,41,43,89,116,138,142],"comparison":[15],"cis(Z)\u2010flupentixol,":[17,95],"fluphenazine,":[18,96],"haloperidol,":[19],"methiothepin,":[20,157],"thioridazine,":[21],"and":[22,40,46,64,97,126,131,141],"clozapine.":[23],"Tefludazine":[24],"showed":[25],"potent":[26,161],"dopamine":[27],"(DA)":[28],"antagonistic":[29],"activity":[30,63,150],"broad":[33],"range":[34],"test":[36],"models":[37],"vitro":[39,111],"vivo":[42],"mice,":[44],"rats,":[45],"dogs":[47],"(receptor":[48],"binding,":[49,113],"antagonism":[50,115,123],"DA":[52,102],"agonist\u2010induced":[53],"behavior,":[54],"inhibition":[55],"conditioned":[57],"avoidance,":[58],"catalepsy,":[59],"etc.).":[60],"High":[61],"oral":[62],"long":[65],"duration":[66],"action":[68],"was":[69,81,105,136],"found.":[70],"Interestingly,":[71],"the":[72,76,86],"cataleptogenic":[73],"potency":[74],"at":[75,107],"time":[77],"peak":[79],"effect":[80,135],"seven":[82],"times":[83],"weaker":[84],"than":[85],"antistereotypic":[87],"activity,":[88],"contrast":[90],"that":[92,155,168,174],"observed":[93],"haloperidol.":[98],"In":[99],"addition":[100],"to":[101],"antagonism,":[103,122],"tefludazine":[104,153,169],"equipotent":[106],"5\u2010HT":[108,114,121],"receptors":[109],"(in":[110],"receptor":[112],"isolated":[117],"peripheral":[118],"tissue,":[119],"cardiovascular":[120],"I\u20105\u2010HTP\u2010":[125],"5\u2010MeODMT\u2010induced":[127],"behaviors).":[128],"No":[129],"antimuscarinic":[130],"low":[132],"\u03b1\u2010adrenoceptor":[133,162],"blocking":[134,163],"found":[137],"pithed":[139],"rats":[140],"denervated":[143],"cat":[144],"nictitating":[145],"membrane":[146],"preparation.":[147],"DA/5\u2010HT":[149],"profile":[151,173],"resembled":[154],"which,":[158],"however,":[159],"had":[160],"effect.":[164],"It":[165],"is":[166],"concluded":[167],"neuropharmacological":[172],"should":[175],"combine":[176],"antipsychotic":[177],"potential":[178],"lower":[180],"risk":[181],"extrapyramidal":[183],"symptoms.":[184]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}